Passage Bio, Inc.PASGNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank71
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-40.41M
↑ 51% vs avg
Percentile
P71
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-82.98M
Historical baseline
PeriodValueYoY Change
TTM$-40.41M+34.9%
2024$-62.09M+36.9%
2023$-98.34M+25.3%
2022$-131.72M+25.2%
2021$-176.19M-58.6%
2020$-111.10M-203.9%
2019$-36.55M-392.7%
2018$-7.42M-